{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:10:31Z","timestamp":1787825431565,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The association of hidradenitis suppurativa with other skin diseases has not yet been investigated in larger studies based on dermatological exams. The objectives of this study are to determine the prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population. Between 2014 and 2017, 20,112 people in 343 German companies were examined for the presence of clinical features of hidradenitis suppurativa within the framework of a cross-sectional epidemiological study based on whole-body examinations. In addition, all cutaneous comorbidities were recorded. Point prevalence was calculated and the differences between individuals with and without hidradenitis suppurativa were determined by bivariate analysis. All statistical procedures were performed using SPSS 23.0 for Windows. Of 20,112 people examined, mean age was 43.6\u2009\u00b1\u200910.5\u00a0years; 52.3% were male. In total,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200957 people (0.3%) with hidradenitis suppurativa were identified; 61.4% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200935) being male. In addition, non-inflammatory hidradenitis suppurativa-related lesions were found in 674 other individuals. In a bivariate comparison, patients with hidradenitis suppurativa showed significantly more frequently the following cutaneous comorbidities: acne vulgaris, psoriasis, seborrhoeic dermatitis, excoriations, and folliculitis. We determined a point prevalence of hidradenitis suppurativa of 0.3%. Since we have examined the working population, the healthy worker effect, which could have led to underestimation of prevalence, cannot be ruled out. The point prevalence of 0.3% for employed people in Germany and a prevalence of 3.0% for inflammatory and non-inflammatory hidradenitis suppurativa-related lesions show that hidradenitis suppurativa is an important disease for the whole health system.\n                  <\/jats:p>","DOI":"10.1007\/s00403-020-02065-2","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:02:40Z","timestamp":1587513760000},"page":"95-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-2309","authenticated-orcid":false,"given":"Natalia","family":"Kirsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-9717","authenticated-orcid":false,"given":"Nicole","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-8728","authenticated-orcid":false,"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"2065_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000444580","volume":"232","author":"LK Andersen","year":"2016","unstructured":"Andersen LK, Davis MD (2016) Prevalence of skin and skin-related diseases in the Rochester epidemiology project and a comparison with other published prevalence studies. Dermatology 232:344\u2013352","journal-title":"Dermatology"},{"key":"2065_CR2","doi-asserted-by":"publisher","first-page":"e0200683","DOI":"10.1371\/journal.pone.0200683","volume":"13","author":"M Calao","year":"2018","unstructured":"Calao M, Wilson JL, Spelman L et al (2018) Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study. PLoS ONE 13:e0200683","journal-title":"PLoS ONE"},{"key":"2065_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","volume":"155","author":"WT Chen","year":"2019","unstructured":"Chen WT, Chi CC (2019) Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol 155:1022\u20131027","journal-title":"JAMA Dermatol"},{"key":"2065_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jaad.2012.07.027","volume":"68","author":"I Cosmatos","year":"2017","unstructured":"Cosmatos I, Matcho A, Weinstein R et al (2017) Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol 68:412\u2013419","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jaad.2016.04.067","volume":"75","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Janse IC, van der Zee HH et al (2016) Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study. J Am Acad Dermatol 75:755\u2013759","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR6","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jid.2018.01.009","volume":"138","author":"A Garg","year":"2018","unstructured":"Garg A, Neuren E, Strunk A (2018) Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States. J Invest Dermatol 138:1288\u20131292","journal-title":"J Invest Dermatol"},{"key":"2065_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/bjd.18003","volume":"181","author":"J Gottlieb","year":"2019","unstructured":"Gottlieb J, Madrange M, Gardair C et al (2019) PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens. Br J Dermatol 181:866\u2013869","journal-title":"Br J Dermatol"},{"key":"2065_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","volume":"35","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35:191\u2013194","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.036","author":"K Kridin","year":"2018","unstructured":"Kridin K, Shani M, Schonmann Y et al (2018) Psoriasis and hidradenitis suppurativa: a large-scale population-based study. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.036","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/1346-8138.12881","volume":"42","author":"I Kurokawa","year":"2015","unstructured":"Kurokawa I, Hayashi N, Japan Acne Research Society (2015) Questionnaire surveillance of hidradenitis suppurativa in Japan. J Dermatol 42:747\u2013749","journal-title":"J Dermatol"},{"key":"2065_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000486741","volume":"233","author":"DE Lee","year":"2017","unstructured":"Lee DE, Clark AK, Shi VY (2017) Hidradenitis suppurativa: disease burden and etiology in skin of color. Dermatology 233:456\u2013461","journal-title":"Dermatology"},{"key":"2065_CR12","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/jdv.15071","volume":"32","author":"JH Lee","year":"2018","unstructured":"Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM (2018) Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol 32:1784\u20131790","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2065_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","volume":"155","author":"MO Machado","year":"2019","unstructured":"Machado MO, Stergiopoulos V, Maes M et al (2019) Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol 155:939\u2013945","journal-title":"JAMA Dermatol"},{"key":"2065_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","volume":"21","author":"ZS Patel","year":"2017","unstructured":"Patel ZS, Hoffman LK, Buse DC et al (2017) Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]. Curr Pain Headache Rep 21:49","journal-title":"Curr Pain Headache Rep"},{"key":"2065_CR15","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/ijd.14500","volume":"58","author":"K Phan","year":"2019","unstructured":"Phan K, Charlton O, Smith SD (2019) Hidradenitis suppurativa and metabolic syndrome\u2014systematic review and adjusted meta-analysis. Int J Dermatol 58:1112\u20131117","journal-title":"Int J Dermatol"},{"key":"2065_CR16","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/jdv.15706","volume":"33","author":"LM Prens","year":"2019","unstructured":"Prens LM, Huizinga J, Janse IC, Horv\u00e1th B (2019) Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study. J Eur Acad Dermatol Venereol 33:1941\u20131946","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2065_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59:596\u2013601","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaad.2018.06.028","volume":"80","author":"A Rondags","year":"2019","unstructured":"Rondags A, van Straalen KR, Arends S et al (2019) High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa. J Am Acad Dermatol 80:551\u2013554.e1","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR19","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A et al (2015) Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 173:1546\u20131549","journal-title":"Br J Dermatol"},{"key":"2065_CR20","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.jaad.2017.10.001","volume":"77","author":"G Shalom","year":"2017","unstructured":"Shalom G, Babaev M, Freud T et al (2017) Demographic and health care service utilization by 4417 patients with hidradenitis suppurativa. J Am Acad Dermatol 77:e2","journal-title":"J Am Acad Dermatol"},{"key":"2065_CR21","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1111\/bjd.15740","volume":"178","author":"H Sonbol","year":"2018","unstructured":"Sonbol H, Duchatelet S, Miskinyte S et al (2018) PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity. Br J Dermatol 178:e17\u2013e18","journal-title":"Br J Dermatol"},{"key":"2065_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/bjd.16998","volume":"180","author":"P Theut Riis","year":"2019","unstructured":"Theut Riis P, Pedersen OB, Sigsgaard V et al (2019) Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study. Br J Dermatol 180:774\u2013781","journal-title":"Br J Dermatol"},{"key":"2065_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.14922","volume":"176","author":"P Theut Riis","year":"2017","unstructured":"Theut Riis P, Thorlacius L, Knudsen List E, Jemec GBE (2017) A pilot study of unemployment in patients with hidradenitis suppurativa in Denmark. Br J Dermatol 176:1083\u20131085","journal-title":"Br J Dermatol"},{"key":"2065_CR24","volume-title":"Dictionnaire de m\u00e9decine, un repertoire g\u00e9n\u00e9rale des Sciences M\u00e9dicals sous le rapport th\u00e9orique et pratique","author":"A Velpeau","year":"1839","unstructured":"Velpeau A (1839) Dictionnaire de m\u00e9decine, un repertoire g\u00e9n\u00e9rale des Sciences M\u00e9dicals sous le rapport th\u00e9orique et pratique, 2nd edn, vol 2. B\u00e9chet jeune, Paris","edition":"2"},{"key":"2065_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/1346-8138.14656","volume":"45","author":"JH Yang","year":"2018","unstructured":"Yang JH, Moon J, Kye YC et al (2018) Demographic and clinical features of hidradenitis suppurativa in Korea. J Dermatol 45:1389\u20131395","journal-title":"J Dermatol"},{"key":"2065_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L et al (2015) European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol 29:619\u2013644","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02065-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:32:56Z","timestamp":1619033576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02065-2","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"19 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}